Publication | Open Access

Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38– cells through iron chelation, induction of ROS, and inhibition of HIF1α expression

Redox SignalingTumor BiologyIron ChelationIron MetabolismApoptosisImmunologyCancer Cell BiologyCell DeathLeukemic Cd34+cd38– CellsReactive Oxygen SpecieMedicineCell BiologyRedox BiologyCancer ResearchOxidative Stress